Financial reports
10-K
2023 FY
Annual report
1 Apr 24
NT 10-Q
Notice of late quarterly filing
15 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
22 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
NT 10-Q
Notice of late quarterly filing
16 Aug 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
Current reports
8-K
Entry into a Material Definitive Agreement
18 Apr 24
8-K
Submission of Matters to a Vote of Security Holders
12 Apr 24
8-K
Regulation FD Disclosure
28 Mar 24
8-K
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
20 Mar 24
8-K
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
18 Mar 24
8-K
Other Events
12 Mar 24
8-K
Results of Operations and Financial Condition
16 Feb 24
8-K
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
15 Feb 24
8-K
Departure of Directors or Certain Officers
5 Jan 24
8-K/A
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 Nov 23
Registration and prospectus
S-1
IPO registration
22 Apr 24
S-3
Shelf registration
24 Aug 23
424B5
Prospectus supplement for primary offering
12 Jul 23
424B5
Prospectus supplement for primary offering
9 Jun 23
424B5
Prospectus supplement for primary offering
5 Jun 23
424B5
Prospectus supplement for primary offering
30 May 23
424B5
Prospectus supplement for primary offering
22 May 23
424B5
Prospectus supplement for primary offering
16 Feb 23
424B5
Prospectus supplement for primary offering
13 Feb 23
S-3
Shelf registration
31 Mar 21
Proxies
DEF 14A
Definitive proxy
4 Mar 24
PRE 14A
Preliminary proxy
15 Feb 24
DEFA14A
Additional proxy soliciting materials
12 Sep 23
DEFA14A
Additional proxy soliciting materials
18 Aug 23
DEF 14A
Definitive proxy
26 Jul 23
PRE 14A
Preliminary proxy
12 Jul 23
DEFA14A
Additional proxy soliciting materials
30 Sep 22
DEFA14A
Additional proxy soliciting materials
26 Aug 22
DEF 14A
Definitive proxy
26 Aug 22
PRE 14A
Preliminary proxy
15 Aug 22
Other
EFFECT
Notice of effectiveness
18 Sep 23
CORRESP
Correspondence with SEC
13 Sep 23
CORRESP
Correspondence with SEC
11 Sep 23
UPLOAD
Letter from SEC
31 Aug 23
SD
Conflict minerals disclosure
1 Jun 21
EFFECT
Notice of effectiveness
12 Apr 21
CORRESP
Correspondence with SEC
7 Apr 21
UPLOAD
Letter from SEC
7 Apr 21
SD
Conflict minerals disclosure
29 May 20
SEC STAFF
SEC staff action: Order
28 Feb 20
Ownership
SC 13D
CR Group L.P.
19 Apr 24
4
Change in insider ownership
16 Apr 24
SC 13G
Safier Jacob
11 Mar 24
SC 13G
New Dimensions Trading
11 Mar 24
4
John J Sperzel III
27 Feb 24
4
John M Sprague
27 Feb 24
4
Michael Terrence Gibbs
27 Feb 24
4
Michael Terrence Gibbs
20 Feb 24
4
John M Sprague
20 Feb 24
4
John J Sperzel III
20 Feb 24